Paid Clinical Trials Paid Clinical Trials > Browse Categories > Medications / Interventions > Aa > Antacids

Antacids

Antacids

All Categories Medications / Interventions » Aa » Antacids


  • Minocycline in the Treatment of Angelman Syndrome

    Condition:   Angelman Syndrome
    Intervention:   Drug: minocycline
    Sponsors:   University of South Florida;   University of South Florida
    Recruiting - verified February 2012
  • Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE)

    Condition:   Pseudoxanthoma Elasticum
    Interventions:   Drug: Magnesium Oxide;   Drug: Placebo
    Sponsors:   Mount Sinai School of Medicine;   Mark Lebwohl
    Not yet recruiting - verified February 2012
  • The Effects of Sevelamer Carbonate on Diabetic Nephropathy

    Condition:   Diabetic Nephropathy
    Interventions:   Drug: Sevelamer Carbonate;   Drug: calcium carbonate
    Sponsors:   Mount Sinai School of Medicine;   Gary Striker
    Not yet recruiting - verified December 2011
  • Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark)

    Condition:   Malaria
    Interventions:   Biological: Pfs25-EPA;   Biological: Pfs25-EPA/Alhydrogel
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified February 2012
  • High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART

    Condition:   HIV-1 Infection
    Interventions:   Drug: Atripla;   Drug: Calcium Carbonate;   Drug: Vitamin D3;   Drug: Placebo for calcium carbonate;   Drug: Placebo for vitamin D3
    Sponsors:   AIDS Clinical Trials Group;   AIDS Clinical Trials Group;   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified February 2012
  • Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With Different Doses of a Novel Adjuvant

    Conditions:   Hookworm Infection;   Hookworm Disease
    Interventions:   Biological: 10 μg Na-GST-1/Alhydrogel;   Biological: 30 μg Na-GST-1/Alhydrogel;   Biological: 100 μg Na-GST-1/Alhydrogel;   Biological: 10 μg Na-GST-1/Alhydrogel with 1 μg GLA-AF;   Biological: 30 μg Na-GST-1/Alhydrogel with 1 μg GLA-AF;   Biological: 100 μg Na-GST-1/Alhydrogel with 1 μg GLA-AF;   Biological: 10 μg Na-GST-1/Alhydrogel with 5 μg GLA-AF;   Biological: 30 μg Na-GST-1/Alhydrogel with 5 μg GLA-AF;   Biological: 100 μg Na-GST-1/Alhydrogel with 5 μg GLA-AF
    Sponsors:   Albert B. Sabin Vaccine Institute;   Albert B. Sabin Vaccine Institute;   Children's Research Institute;   George Washington University
    Recruiting - verified May 2012
  • Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study

    Condition:   SARS
    Interventions:   Drug: Aluminum hydroxide adjuvant (Alhydrogel®);   Other: Phosphate buffered saline Placebo;   Biological: Recombinant S protein SARS vaccine
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)
    Not yet recruiting - verified April 2012
  • Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules

    Condition:   Rotavirus
    Interventions:   Biological: RotaTeq®;   Biological: Rotarix®
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified March 2012
  • Impact of Vitamin D on Diabetic Kidney Disease in African Americans

    Condition:   Diabetic Kidney Disease
    Interventions:   Drug: Vitamin D3;   Drug: Vitamin D3
    Sponsors:   Medical University of South Carolina;   Medical University of South Carolina
    Recruiting - verified October 2010
  • Multisite Controlled Trial of Cocaine Vaccine

    Condition:   Cocaine Dependence
    Interventions:   Drug: TA-CD Vaccination;   Other: Placebo Injection
    Sponsors:   Baylor College of Medicine;   Baylor College of Medicine;   National Institute on Drug Abuse (NIDA);   US Department of Veterans Affairs Cooperative Studies Program;   VA Maryland Health Care System;   Columbia University;   VA New York Harbor Healthcare System;   University of Pennsylvania;   Johns Hopkins University;   University of Cincinnati;   Celtic Pharma Development Services
    Recruiting - verified September 2011
  • Safety and Effectiveness of Oral Alendronate Therapy on Bone Mineral Density in HIV-infected Children and Adolescents With Low Bone Mineral Density

    Condition:   HIV Infections
    Interventions:   Drug: Alendronate;   Drug: Alendronate placebo;   Dietary Supplement: Calcium carbonate/vitamin D
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting - verified May 2012
  • Vitamin D, Insulin Resistance, and Cardiovascular Disease

    Conditions:   Vitamin D Deficiency;   Insulin Resistance;   Type 2 Diabetes Mellitus;   Cardiovascular Disease;   Hypertension
    Interventions:   Drug: Vitamin D3;   Drug: Placebo
    Sponsors:   Washington University School of Medicine;   Washington University School of Medicine;   National Heart, Lung, and Blood Institute (NHLBI);   American Diabetes Association
    Recruiting - verified November 2011
  • Effect of Calcium on Gleevec Pharmacokinetics (PK) in Healthy Volunteers

    Condition:   Healthy
    Interventions:   Drug: Imatinib mesylate;   Dietary Supplement: calcium carbonate
    Sponsors:   University of Pittsburgh;   University of Pittsburgh;   Novartis Pharmaceuticals
    Recruiting - verified November 2011

Main Menu
Clinical Trial Categories
Clinical Trial Locations